Topical Delivery by Iontophoresis

Handbook of Cosmetic Science and Technology, Second Edition

Volumn , Issue , 2005, Pages 189-200

  Preat, Véronique ^a   Wascotte, Valentin ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860397655     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14400-17     Document Type: Chapter

References (95)

1. Hadgraft J, Guy RH. Transdermal drug delivery. New York: Marcel Dekker, 2003.
2. Naik A, Kalia YN, Guy RH. Transdermal drug delivery; overcoming the skin’s barrier function. PSST 2000; 3:318–326.
3. Walters K, Hadgraft J, eds. Pharmaceutical skin permeation enhancement. New York: Marcel Dekker, 1993.
4. Barry B, Williams A. Parmeation enhancement through skin. In: Swarbick J, Boylan J, eds. Encyclopedia of Pharmaceutical Technology. 11. 1995; 449–493.
5. Sage B. Iontophoresis. In: Swarbick J, Boylan J, eds. Encyclopedia of Pharmaceutical Technology. 8. 1993;217–247.
6. Singh P, Maibach H. Iontophoresis in drug delivery: basic principles and applications. Crit Rev Therap Drug Carrier Syst 1994; 11:161–213.
7. Singh P, Maibach H. Iontophoresis: an alternative to the use of carriers in cutaneous drug delivery. Adv Drug Del Rev 1996; 18:379–394.
8. Roberts M, Lai M, Cross S, Yoshida N. Solute transport as a determinant of iontophoretic transport. In: Potts R, Guy RH, eds. Mechanisms of Transdermal Drug Delivery. New York: Marcel Dekker, 1997:291–349.
9. Delgado-Charro MB, Guy RH. Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. STP Pharm 2001; 11:403–414.
10. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Del Rev 2004; 56:619–658.
11. Banga A. Clinical applications of iontophoresis devices for topical dermatological delivery. In: Banga A, ed. Electrically Enhanced Transdermal Drug Delivery. Taylor & Francis, 1998:57–74.
12. Gargarosa L, Ozawa A, Ohkido M, Shimomura Y, Hill J. Iontophoresis for enhancing penetration of dermatologic and antiviral drugs. J Dermatol 1995; 22:865–875.
13. Gargarosa L, Hill M. Modern iontophoresis for local drug delivery. Int J Pharm 1995; 123:159–171.
14. Singh J, Bhatia K. Topical iontophoretic drug delivery: pathways, principles, factors and skin irritation. Med Res Rev 1996; 16:285–296.
15. Costello C, Jeshe A. Iontophoresis: applications in transdermal medication delivery. Phys Ther 1995; 75:554–563.
16. Green P. Iontophoretic delivery of peptides drug. J Control Release 1996; 41:33–48.
17. Phipps JB, Gyory J. Transdermal ion migration. Adv Drug Del Rev 1992; 9:137–176.
18. Pikal M. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Del Rev 1992; 9:201–237.
19. Hirvonen Y, Guy RH. Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J Control Release 1998; 50:283–289.
20. Rao G, Guy RH, Glikfeld P, LaCourse W, Leung L, Tamada J, Potts R, Azimi N. Reverse iontophoresis: non invasive glucose monitoring in vivo in humans. Pharm Res 1995; 12:1869–1873.
21. Cullander C. What are the pathways of iontophoretic current flow through mammalian skin? Adv Drug Del Rev 1992; 9:119–135.
22. Scott E, Laplazza A, White H, Phipps B. Transport of ionic species in skin: contribution of pores to the overall skin conductance. Pharm Res 1993; 10:1699–1709.
23. Monteiro-Riviére N. Identification of the pathways of transdermal iontophoretic drug delivery: light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 1994; 11:251–256.
24. Turner N, Ferry L, Price M, Cullander C, Guy RH. Iontophoresis of poly-L-lysines: the role of molecular weight. Pharm Res 1997; 14:1322–1331.
25. Regnier V, Préat V. Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm Res 1998; 15:1596–1602.
26. Préat V, Vanbever R, Jadoul A, Regnier V. Electrically enhanced transdermal drug delivery: iontophoresis vs electroporation. In: Couvreur P, Ducheˆne D, Green P, Junginger H, eds. Transdermal Administration, A Case Study, Iontophoresis. Paris: Editions de la santé, 1997:58–67.
27. Jadoul A, Mesens J, de Beukelaer F, Crabbé R, Préat V. Transdermal permeation of alnitidan by iontophoresis: in vitro optimization and human pharmacokinetic data. Pharm Res 1996; 13:1347–1352.
28. Jadoul A, Bouwstra J, Préat, V. Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Del Rev 1999; 35:89–106.
29. Kalia Y, Nomato LD, Guy RH. The effect of iontophoresis on skin barrier integrity: non invasive investigation by impedance spectroscopy and transepidermal water loss. Pharm Res 1996; 13:957–961.
30. Craane-vanHinsberg W, Verhoef J, Spies F, Bouwstra J, Gooris G, Junginger H, Boddé H. Electroperturbation on the human skin barrier in vitro (I) the influence of current density on the thermal behaviour of skin impedance. Eur J Pharm Biopharm 1997; 43:43–50.
31. Thysman S, Van Neste D, Préat V. Non invasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol 1995; 8:229–236.
32. Jadoul A, Doucet J, Durand D, Préat V. Modifications induced on stratum corneum by iontophoresis:ATR-FTIR and X-ray scattering studies. J Control Release 1996; 42:165–173.
33. Fouchard D, Hueber F, Teillaud E, Marty JP. Effect of iontophoretic current flow on hairless rat skin in vivo. J Control Release 1997; 49:89–99.
34. Vandergeest R, Elshove D, Danhof M, Lavrijsen A, Boddé H. Non-invasive assessment of skin barrier integrity and skin irritation following iontophoretic current application in humans. J Control Release 1996; 41:205–213.
35. Vanbever R, Fouchard D, Jadoul A, De Morre N, Préat V, Marty JP. In vivo non-invasive evaluation of hairless rat skin after high-voltage pulse exposure. Skin Pharmacol Appl Skin Physiol 1998; 11:23–34.
36. Singh J, Gross M, Sage B, Davis HT, Maibach HI. Effect of saline iontophoresis on skin barrier function and cutaneous irritation in four ethnic groups. Food Chem Toxicol 2000; 38:717–726.
37. Singh J, Gross M, Sage B, Davis HT, Maibach HI. Regional variations in skin barrier function and cutaneous irritation due to iontophoresis in human subjects. Food Chem Toxicol 2001; 39:1079–1086.
38. Ledger P. Skin biological in electrically enhanced transdermal delivery. Adv Drug Del Rev 1992; 9:289–307.
39. Prausnitz M. The effects of electric current applied to skin: a review for transdermal drug delivery. Adv Drug Del Rev 1996; 18:395–425.
40. Tierney MJ, Tamada JA, Potts RO, Jovanovi L, Garg S. Cygnus Research Team. Clinical evaluation of the Glucowatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron 2001; 16:621–629.
41. Jadoul A, Hanchard C, Thysman S, Préat V. Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin. Int J Pharm 1995; 120:221–228.
42. Stagni G, Ehsan Ali M, Weng D. Pharmacokinetics of acyclovir in rabbit skin after IV-bolus, ointment and iontophoretic administrations. Int J Pharm 2004; 274:201–211.
43. Gibson L, Cooke R. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959; 23:545.
44. Hill A, Baker G, Jansen G. Mechanism of action of iontophoresis in the treatment of palmar hyperhidrosis. Cutis 1981; 28:69–72.
45. Holzle E, Alberti N. Long term efficacy and side effects of tap water iontophoresis of palmoplantar hyperhidrosis-the usefulness of home therapy. Dermatologica 1987; 175:126.
46. Russo J, Lipman AG, Comstock TJ, Page BC, Stephen RL. Lidocaine anesthesia: comparison of iontophoresis, injection and swabbing. AmJ Hosp Pharm 1980; 37:843–847.
47. Maloney JM, Bezzant JL, Stephen RL, Petelenz TJ. Iontophoretic administration of lidocaine anaesthesia in office practice an appraisal. J Dermatol Surg Oncol 1992; 18:937–940.
48. Ashburn MA, Gauthier M, Love G, Basta S, Gaylord B, Kessler K. Iontophoretic administration of 2% lidocaine HCl and 1:100.000 epinephrine in humans. Clin J Pain 1997; 13:22–26.
49. Rose JB, Galinkin JL, Jantzen EC, Chiavacci RM. A study of lidocaine iontophoresis for pediatric venipuncture. Anesth Analg 2002; 94:867–871.
50. Zempsky WT, Parkinson TM. Lidocaine iontophoresis for local anesthesia before shave biopsy. Dermatol Surg 2003; 29:627–630.
51. Kennard CD, Whitaker DC. Iontophoresis of lidocaine for anesthesia during pulsed dye laser treatment of port-wine stains. J Dermatol Surg Oncol 1992; 18:287–294.
52. Nunez M, Miralles ES, Boixeda P, Gomez F, Perez B, Abraira V, Ledo A. Iontophoresis for anesthesia during pulsed dye laser treatment of port-wine stains. Pediatr Dermatol 1997; 14:397–400.
53. Bezzant JL, Stephen RL, Petelenz TJ, Jacobsen SC. Painless cauterization of spider veins with the use of iontophoretic local anesthesia. J Am Acad Dermatol 1988; 19:869–875.
54. Greenbaum SS. Iontophoresis as a tool for anesthesia in dermatologic surgery: an overview. Dermatol Surg 2001; 27:1027–1030.
55. DeCou JM, Abrams RS, Hammond JH, Lowder LR, Gauderer MW. Iontophoresis: a needle-free, electrical system of local anesthesia delivery for pediatric surgical office procedures. J Pediatr Surg 1999; 34:946–949.
56. Lener EV, Bucalo B, Kist D, Moy R. Topical anesthetic agents in dermatologic surgery: a review. Dermatol Surg 1997; 23:673–683.
57. Riviere JE, Montiero-Riviere NA, Inman AO. Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharm Res 1992; 9:211–214.
58. Wallace MS, Ridgeway B, Jun E, Schulteis G, Rabussay D, Zhang L. Topical delivery of lidocaine in healthy volunteers by electroporation, electroincorporation, or iontophoresis: an evaluation of skin anesthesia. Regional Anesth Pain Med 2001; 26:229–238.
59. Irsfeld S, Klement W, Lipfert P. Dermal anaesthesia: comparison of EMLA cream with iontophoretic local anaesthesia. Br J Anaesth 1993; 71:375–378.
60. Bjerring P, Arendt-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth 1990; 64:173–177.
61. Galinkin JL, Rose JB, Harris K, Watcha MF. Lidocaine iontophoresis versus eutectic mixture of local anesthetics (EMLA) for IV placement in children. Anesth Analg 2002; 94:1484–1488.
62. Greenbaum SS, Bernstein EF. Comparison of iontophoresis of lidocaine with a eutectic mixture of lidocaine and prilocaine (EMLA) for topically administered local-anesthesia. J Dermatol Surg Oncol 1994; 20:579–583.
63. Wahlgren CF, Quiding H. Depth of cutaneous analgesia after application of a eutectic mixture of the local anesthetics lidocaine and prilocaine (EMLA cream). J Am Acad Dermatol 2000; 42:584–588.
64. Curdy C, Kalia YN, Naik A, Guy RH. Piroxicam delivery into human stratum corneum in vivo : iontophoresis versus passive diffusion. J Control Release 2001; 76:73–79.
65. Fang JY, Sung KC, Hung-Hong L, Fang CL. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm 1999; 178:83–92.
66. Hui X, Anigbogu A, Singh P, Xiong G, Poblete N, Liu P, Maibach HI. Pharmacokinetic and local tissue disposition of [14C] sodium diclofenac following iontophoresis and systemic administration in rabbits. J Pharm Sci 2001; 90:1269–1276.
67. Garagiola U, Dacatra U, Braconaro F, Porretti E, Pisetti A, Azzolini V. Iontophoretic administration of pirprofen or lysine soluble aspirin in treatment of rheumatic diseases. Clin Ther 1988; 10:553–558.
68. Saggini R, Zoppi M, Vecchiet F, Gatteschi L, Obletter G, Giamberardino MA. Comparison of electromotive drug administration with ketorolac or with placebo in patients with pain from rheumatic disease: a double masked study. Clin Ther 1996; 18:1169–1174.
69. Panus PC, Campbell J, Kulkarni SB, Herrick RT, Ravis WR, Banga AK. Transdermal iontophoretic delivery of ketoprofen through human cadaver skin and in humans. J Control Release 1997; 44:113–121.
70. Hasson S, Daniels J, Schieb, D. Exercise training and dexamethasone iontophoresis in rheumatoid arthritis. Physiotherapy Canada 1991; 43:11–14.
71. Bertolucci LE. Introduction of antiinflammatory drugs by iontophoresis: double blind study. J Orthop Sports Phys Ther 1982; 4:103–108.
72. Glass JM, Stephen RL, Jacobson SC. The quantity and distribution of radiolabeled dexamethasone delivery to tissue by iontophoresis. Int J Dermatol 1980; 19:519–525.
73. Petelenz TJ, Buttke JA, Bonds C, Lloyd LB, Beck JE, Stephen RL, Jacobsen SC, Rodriguez P. Iontophoresis of dexamethasone: laboratory studies. J Control Release 1992; 20:55–66.
74. Lopez RFV, Bentley MVL, Delgado-Charro MB, Guy RH. Optimization of aminolevulinic acid delivery by iontophoresis. J Control Release 2003; 88:65–70.
75. Lopez RFV, Bentley MVL, Delgado-Charro MB, Guy RH. Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm Res 2001; 18:311–315.
76. Rhodes L, Tsoukas M, Anderson R, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997; 108:87–91.
77. Alvarez-Figueora MJ, Delgado-Charro MB, Blanco-Mendez J. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm 2001; 212:101–107.
78. Alvarez-Figueora MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001; 215:57–65.
79. Stagni G, Shukla C. Pharmacokinetics of methotrexate in rabbit skin and plasma after iv-bolus and iontophoretic administrations. J Control Release 2003; 93:283–292.
80. Marconi B, Mancini F, Colombo P, Allegra F, Gioardano F, Gazzaniga A, Orecchia G, Santi P. Distribution of khellin in excised human skin following iontophoresis and passive dermal transport. J Control Release 1999; 60:261–268.
81. Boinpally RR, Zhou SL, Devraj G, Anne PK, Poondru S, Jasti BJ. Iontophoresis of lecithin vesicles of cyclosporin A. Int J Pharm 2004; 274:185–190.
82. Volpato NM, Nicoli S, Laureri C, Colombo P, Santi P. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J Control Release 1998; 50:291–296.
83. Volpato NM, Sauli P, Colombo P. Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis. Pharm Res 1995; 12:1623–1627.
84. Park NH, Gangarosa LP, Kwon BS, Hill JM. Iontophoretic application of adenine arabinoside monophosphate to herpes simplex virus type 1-infected hairless mouse skin. Antimicrob Agents Chemother 1978; 14:605–608.
85. Park NH, Gangarosa LP, Hill JM. Iontophoretic application of ara-AMP (9-b-Darabinofuranosyladenine-50-monophosphate) into adult mouse skin. Proc Soc Exp Biol Med 1977; 156:326–329.
86. Gordon A, Weinstein M. Sodium salicylate iontophoresis in the treatment of plantar warts. Phys Ther 1968; 49:869.
87. Kahn J. Acetic acid iontophoresis for calcium deposit. Phys Ther 1977; 57:658.
88. Asai J, Fukuta K, Torii S. Topical administration of prostaglandin E1 with iontophoresis for skin flap viability. Ann Plast Surg 1997; 38:514–517.
89. Saeki S, Yamamura K, Matsushita M, Niishikimi N, Sakurai T, Nimura Y. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation. Int J Clin Pharmacol Ther 1998; 36:525–529.
90. Ebihara M, Akyama M, Ohnishi Y, Tajima S, Komata K, Mitsui Y. Iontophoresis promotes percutaneous absorption of L-ascorbic acid in rat skin. J Dermatol Sci 2003; 32:217–222.
91. Thysman S, Jadoul A, Leroy T, Van Neste D, Préat V. Laser Doppler evaluation of skin reaction in volunteers after histamine iontophoresis. J Control Release 1995; 36:215–219.
92. Leroy T, Tasset C, Valentin B, Van Neste D. Comparison of the effects of cetirizine and ebasine on the skin response to histamine iontophoresis monitored with laser Doppler flowmetry. Dermatology 1998; 197:146–151.
93. Schmidt JB, Binder M, Macheines UV, Bieglmager C. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin. Int J Dermatol 1995; 34:53–57.
94. Shigeni S, Murakami T, Yata N, Ikuta Y. Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast. Scan J Plast Reconstr Surg Hand Surg 1997; 31:151–158.
95. Zhao L, Hung L, Choy T. Delivery of medication by iontophoresis to treat post-burn hypertrophic scars: investigation of a new electronic technique. Burns 1997; 23(suppl 1): S27–S29.